As we continue to navigate the evolving landscape of compliance in the pharmaceutical industry, the role of artificial intelligence (AI) is becoming increasingly pivotal. At the upcoming Pharmaceutical Compliance Congress (PCC) 2025, RLDatix Life Sciences is proud to be part of a dynamic panel discussion titled “How to Leverage AI in Compliance Function,” featuring our VP, Product Development, Gaurav Sharma alongside Christine Zettlemoyer, Senior Vice President, Global Head of Compliance, Risk, and Data Privacy Program at Genmab and Christian Dingler, Executive Director, Risk Management and Program Effectiveness at Insmed.
The Power of AI in Compliance
AI is revolutionizing how organizations manage risk and ensure regulatory adherence. By leveraging AI, companies can enhance risk identification, automate routine compliance tasks, and implement predictive analytics to stay ahead of emerging challenges. However, this integration also raises important questions about AI governance, bias detection, and regulatory compliance.
Key Discussion Points
During the session, the speakers will delve into several critical areas:
- Expectations from the Compliance function in AI-enabled companies, and their implications
- Current AI initiatives in Compliance – benefits, challenges, and lessons learnt
- The path forward – exciting possibilities and key risks
Why Attend
Join us at PCC 2025 to gain insights into how AI is transforming compliance functions and risk management. This session is a must-attend for anyone in compliance and risk management, offering strategies to stay ahead in the field. You will have the opportunity to engage with industry experts, network with peers, and enhance your understanding of AI’s role in compliance.
Event Details
- Date: Tuesday, April 29th
- Time: 4:55pm – 5:50pm
We look forward to seeing you there!